23 C Health & Fitness / The Economic Times
NephroPlus, India's largest dialysis chain, has secured $103 million (860 crore) in a Series F funding round led by Quadria Capital. This funding, a mix of fresh capital and a secondary sale, aims to drive expansion plans within India and targeted markets overseas. The primary component of the funding is 100 crore. Quadria Capital will become a minority shareholder, valuing NephroPlus at over 2,000 crore. Existing investors like Bessemer Venture Partners, International Finance Corporation, and I
Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.
Since January, Congo has reported more than 4,500 suspected mpox cases and nearly 300 deaths, numbers that have roughly tripled from the same period last year, according to the World Health Organization. Congo recently declared the outbreak across the country a health emergency.
Delius Pharma registered a 35 percent rise in sales in FY23 to 24, with plans to set up multiple manufacturing units in India for finished formulation and API production.
Max Healthcare Institute Ltd plans to invest Rs 2,500 crore in Uttar Pradesh (UP) which includes setting up of a new 500 beds hospital on 5.6-acre parcel of land located at Shaheed Path and augmentation of capacity of the acquired facility.
The study, which is the fourth edition of its flagship Health of Nation Report, highlighted the fastest rise in cancer cases and also the average age of incidence has also gotten significantly younger in India.